Clinical Trials on Intracranial Neoplasm in Japan

Total 2662 results

Kosei Hasegawa, MD, PhD

Recruiting

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Carcinoma, Ovarian Epithelial

Japan
Osaka University
Japan Agency for Medical Research and Development

Recruiting

Clinical Trial of Targeted Alpha Therapy for Prostate Cancer (Alpha-PS1)

Prostate Cancer

Japan
AstraZeneca

Completed

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

Carcinoma, Non-Small-Cell Lung

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Gastric Cancer | Gastric Adenoma | Colon Nos Polypectomy Tubular Adenoma

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Thyroid Neoplasms

Japan
Kyoto University

Withdrawn

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Localized Resectable Adult Primary Liver Cancer | Stage III Childhood Liver Cancer

Japan
Bayer

Completed

Regorafenib Post-marketing Surveillance in Japan

Gastrointestinal Stromal Tumors

Japan
AstraZeneca

Completed

A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

Metastatic Colorectal Cancer

Japan
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Withdrawn

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

Gastric Cancer

Japan
Shiga University
Tokyo University

Completed

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
Shiga University
Tokyo University

Completed

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
University of Yamanashi
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Esophageal Cancer

Japan
University of Yamanashi
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Esophageal Cancer

Japan
Eli Lilly and Company

Completed

Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas

Adenocarcinoma

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of DS-1123a in Advanced Solid Tumours

Advanced Solid Malignant Tumors

Japan
Daiichi Sankyo Co., Ltd.

Terminated

Open Label Study of DS-5573a

Advanced Solid Malignant Tumors

Japan
Eli Lilly and Company

Completed

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

Solid Tumors

Japan
Celgene

Recruiting

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Lymphoma Nonhodgkin

Japan
Merck KGaA, Darmstadt, Germany
Threshold Pharmaceuticals

Terminated

A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Soft Tissue Sarcoma

Japan
University of Yamanashi

Unknown

Study of Chemo-Immunotherapy in Head and Neck Cancer Patients

Head and Neck Cancer

Japan
AbbVie (prior sponsor, Abbott)

Completed

A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors

Solid Tumors

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KRN951 in Patients With Solid Tumors

Solid Tumors

Japan
Showa Inan General Hospital

Completed

The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

Gastric Cancer | Helicobacter Pylori | Eradication | Medical Care Cost

Japan
Eisai Co., Ltd.

Completed

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures (FYC02T)

Partial Seizures (With or Without Secondary Generalized Seizures) | Primary Generalized Tonic-clonic Seizures

Japan
Comprehensive Support Project for Oncology Research

Completed

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (RESPECT)

Breast Cancer

Japan
Showa Inan General Hospital

Completed

Prospective Randomized Comparison of Cold Snare Polypectomy and Conventional Polypectomy (COLD)

Colorectal Cancer

Japan
Eisai Co., Ltd.

Completed

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures (FYC01S)

Partial Seizures (With or Without Secondary Generalized Seizures) | Primary Generalized Tonic-clonic Seizures

Japan
Shiga University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

Japan
Shiga University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer

Small Cell Lung Cancer

Japan
AstraZeneca

Completed

A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients

Carcinoma | Cancer | Tumors

Japan
Bayer

Completed

Treatment Satisfaction With Ra-223 in Japan

Prostatic Neoplasms

Japan
Eli Lilly and Company

Completed

A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body

Pancreatic Neoplasms

Japan
National Cancer Center, Japan
Merck Sharp & Dohme LLC

Recruiting

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) (Artemis)

Untreated Advanced or Recurrent Thymic Carcinomas

Japan
Chinese University of Hong Kong
Changi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaborators

Completed

RCT of Gastric ESD With or Without Epineprhine Added Solution

Early Gastric Cancer | Gastric Neoplasm

Japan, Singapore, Korea, Republic of, Hong Kong
Eisai Inc.

Completed

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Cancer: Solid Tumors

Japan
Shoichi Fujii, MD, PhD

Unknown

Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Anterior Resection

Rectal Cancer | Colon Rectal Resection

Japan
Mie University

Completed

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Adrenal Tumors

Japan
Novartis Pharmaceuticals

Completed

An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor

Advanced Solid Tumors

Japan
Eli Lilly and Company
Parexel

Completed

Study of IMC-1121B in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Japan
AstraZeneca

Completed

Open Label, Dose Escalation Phase I Study of AZD2281

Advanced Solid Malignancies

Japan
Daiichi Sankyo Co., Ltd.

Completed

An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

Cervical Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Gastric Cancer (Inoperable and Recurrent)

Japan
OncoTherapy Science, Inc.

Terminated

Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

Relapsed or Refractory Synovial Sarcoma

Japan
Shizuoka Cancer Center

Completed

Tissue Oxygen Saturation for Esophagectomy

Esophageal Neoplasms | Anastomotic Leak | Oxygen Deficiency | Esophagostomy Complication

Japan
Shiga University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Cancer | Solid Tumors | Advanced Solid Malignancies

Japan
Boehringer Ingelheim

Completed

Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours

Neoplasms

Japan
Bayer

Completed

Japanese BAY80-6946 Monotherapy Phase I Study

Neoplasms

Japan
Eisai Inc.

Completed

A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Japan
Shiga University

Completed

A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
Translational Research Center for Medical Innovation...
Keio University; Jikei University School of Medicine

Completed

CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）

Cervical Cancer

Japan

3

Subscribe